From Clinical Trial to the Real-World: Data on Pediatric Hematopoietic Cell Transplantation for Acute Myeloid Leukemia from the Children's Oncology Group (COG) and Center for International Blood and Marrow Transplant Research (CIBMTR) | Synapse
March 3, 2026
From Clinical Trial to the Real-World: Data on Pediatric Hematopoietic Cell Transplantation for Acute Myeloid Leukemia from the Children's Oncology Group (COG) and Center for International Blood and Marrow Transplant Research (CIBMTR)
Key Points
Real-world data shows the effectiveness of hematopoietic cell transplantation for acute myeloid leukemia in children.
Key metrics from the Children's Oncology Group reveal notable survival rates in pediatric patients after transplantation.
Observational analysis across multiple centers highlights the transition from clinical trials to real-world applications in oncology.
Findings may enable improved treatment plans for pediatric acute myeloid leukemia, enhancing patient care.